Barclays
OCDX

Barclays’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Barclays’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,774
Closed -$761K – 5495
2022
Q1 		$761K Buy
+40,774
New +$734K ﹤0.01% 2604

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's OCDX Position: Q2 2022 in Review

Barclays sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 40,774 shares — an estimated $761K sold.

Barclays first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $761K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Barclays reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 40,774 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $761K.
  • Barclays first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Barclays's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $761K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.